Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Phase A (Weeks 0 to 24)	STARTED	Omarigliptin	165
Phase A (Weeks 0 to 24)	STARTED	Placebo to Omarigliptin	164
Phase A (Weeks 0 to 24)	COMPLETED	Omarigliptin	147
Phase A (Weeks 0 to 24)	COMPLETED	Placebo to Omarigliptin	151
Phase A (Weeks 0 to 24)	NOT COMPLETED	Omarigliptin	18
Phase A (Weeks 0 to 24)	NOT COMPLETED	Placebo to Omarigliptin	13
Interphase	STARTED	Omarigliptin	147
Interphase	STARTED	Placebo to Omarigliptin	151
Interphase	COMPLETED	Omarigliptin	146
Interphase	COMPLETED	Placebo to Omarigliptin	151
Interphase	NOT COMPLETED	Omarigliptin	1
Interphase	NOT COMPLETED	Placebo to Omarigliptin	0
Phase B (Weeks 24 to 54)	STARTED	Omarigliptin	146
Phase B (Weeks 24 to 54)	STARTED	Placebo to Omarigliptin	151
Phase B (Weeks 24 to 54)	COMPLETED	Omarigliptin	134
Phase B (Weeks 24 to 54)	COMPLETED	Placebo to Omarigliptin	135
Phase B (Weeks 24 to 54)	NOT COMPLETED	Omarigliptin	12
Phase B (Weeks 24 to 54)	NOT COMPLETED	Placebo to Omarigliptin	16

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01717313/flow